These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. The CXCL7/CXCR1/2 axis is a key driver in the growth of clear cell renal cell carcinoma. Grépin R, Guyot M, Giuliano S, Boncompagni M, Ambrosetti D, Chamorey E, Scoazec JY, Negrier S, Simonnet H, Pagès G. Cancer Res; 2014 Feb 01; 74(3):873-83. PubMed ID: 24335961 [Abstract] [Full Text] [Related]
28. The chemokine receptors CXCR1/CXCR2 modulate antigen-induced arthritis by regulating adhesion of neutrophils to the synovial microvasculature. Coelho FM, Pinho V, Amaral FA, Sachs D, Costa VV, Rodrigues DH, Vieira AT, Silva TA, Souza DG, Bertini R, Teixeira AL, Teixeira MM. Arthritis Rheum; 2008 Aug 02; 58(8):2329-37. PubMed ID: 18668539 [Abstract] [Full Text] [Related]
29. CXCR1 and CXCR2 silencing modulates CXCL8-dependent endothelial cell proliferation, migration and capillary-like structure formation. Singh S, Wu S, Varney M, Singh AP, Singh RK. Microvasc Res; 2011 Nov 02; 82(3):318-25. PubMed ID: 21749879 [Abstract] [Full Text] [Related]
30. Differential activation and regulation of CXCR1 and CXCR2 by CXCL8 monomer and dimer. Nasser MW, Raghuwanshi SK, Grant DJ, Jala VR, Rajarathnam K, Richardson RM. J Immunol; 2009 Sep 01; 183(5):3425-32. PubMed ID: 19667085 [Abstract] [Full Text] [Related]
31. Rabbit neutrophil chemotactic protein (NCP) activates both CXCR1 and CXCR2 and is the functional homologue for human CXCL6. Catusse J, Struyf S, Wuyts A, Weyler M, Loos T, Gijsbers K, Gouwy M, Proost P, Van Damme J. Biochem Pharmacol; 2004 Nov 15; 68(10):1947-55. PubMed ID: 15476666 [Abstract] [Full Text] [Related]
33. Functional activity of CXCL8 receptors, CXCR1 and CXCR2, on human malignant melanoma progression. Gabellini C, Trisciuoglio D, Desideri M, Candiloro A, Ragazzoni Y, Orlandi A, Zupi G, Del Bufalo D. Eur J Cancer; 2009 Sep 15; 45(14):2618-27. PubMed ID: 19683430 [Abstract] [Full Text] [Related]
34. LPS challenge in healthy subjects: an investigation of neutrophil chemotaxis mechanisms involving CXCR1 and CXCR2. Aul R, Patel S, Summerhill S, Kilty I, Plumb J, Singh D. Int Immunopharmacol; 2012 Jul 15; 13(3):225-31. PubMed ID: 22561413 [Abstract] [Full Text] [Related]
37. Neutrophil chemotaxis caused by chronic obstructive pulmonary disease alveolar macrophages: the role of CXCL8 and the receptors CXCR1/CXCR2. Kaur M, Singh D. J Pharmacol Exp Ther; 2013 Oct 15; 347(1):173-80. PubMed ID: 23912333 [Abstract] [Full Text] [Related]
38. Identification of a putative intracellular allosteric antagonist binding-site in the CXC chemokine receptors 1 and 2. Nicholls DJ, Tomkinson NP, Wiley KE, Brammall A, Bowers L, Grahames C, Gaw A, Meghani P, Shelton P, Wright TJ, Mallinder PR. Mol Pharmacol; 2008 Nov 15; 74(5):1193-202. PubMed ID: 18676678 [Abstract] [Full Text] [Related]
39. A potent and selective nonpeptide antagonist of CXCR2 inhibits acute and chronic models of arthritis in the rabbit. Podolin PL, Bolognese BJ, Foley JJ, Schmidt DB, Buckley PT, Widdowson KL, Jin Q, White JR, Lee JM, Goodman RB, Hagen TR, Kajikawa O, Marshall LA, Hay DW, Sarau HM. J Immunol; 2002 Dec 01; 169(11):6435-44. PubMed ID: 12444152 [Abstract] [Full Text] [Related]